Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vistin Pharma Director's Dealing 2021

May 19, 2021

3782_dirs_2021-05-19_a755772a-0ebb-41ab-b19e-f5aa8b2d5e94.html

Director's Dealing

Open in viewer

Opens in your device viewer

Vistin Pharma ASA: Mandatory notification of trade

Vistin Pharma ASA: Mandatory notification of trade

Hilde Merete Hagen, VP Quality & regulatory Affairs in Vistin Pharma ASA, and a

primary insider, has on 18th of May 2021 sold 14 182 shares in Vistin Pharma ASA

at an average price of NOK 24.0 per share.

Following this transaction Hilde Merete Hagen do not hold any shares in Vistin

Pharma ASA.